U.S. Clinical Nutrition Market will exhibit robust growth during 2023-2032, attributed to the growing prevalence of chronic disorders and high consumption of junk food.

Junk food consumption has increased dramatically in recent years due to hectic lifestyles and a high preference for fast food. However, this scenario has aggravated health concerns, particularly across Western nations, with growing incidences of malnourishment and nutrient deficiencies. Fast foods lack a rich nutritional profile and are devoid of vitamins. As per the USDA, in December 2021, spending across limited-service and full-service restaurants were 10% higher than in December 2019.

Majority of young adults and children in the U.S. eat junk food, resulting in a lack of essential nutrients causing deficiencies and poor growth. According to a survey conducted by the National Center for Health Statistics in 2022, more than 36.5% of the American adult population consumes junk food on any given day.

The market is segmented into product, consumer, application, distribution channel, and dosage formulation.

Based on product, the U.S. clinical nutrition market share from enteral nutrition exceeded USD 4 billion in 2022. The increasing patient pool of chronic diseases is expected to drive the demand for enteral nutrition products, which are administered to patients in an ICU, CCU, and other home care settings. These products offer myriad advantages, including optimization of gut function, improvement of insulin sensitivity & glycemic control, and the ability to overcome nutritional deficiencies.

In terms of consumer, the industry is segmented into adult and pediatric. Among these, the demand for clinical nutrition among adult consumers is set to rise notably over 2032, driven by the growing concerns associated with malnutrition. The aging population is more susceptible to nutritional deficiencies, and aging-related metabolic disorders such as cardiac and chronic nutritional imbalance, and renal, and liver problems.

With regards to application, the market is classified into gastrointestinal disorders, metabolic disorders, neurological disorders, cancer, and others. The gastrointestinal disorders segment will surpass USD 7.8 billion by 2032 due to the rising prevalence of gut health issues among undernourished patients. Lack of adequate nutrition is a major cause of gastrointestinal conditions such as stomach cramping, discomfort, slow gastric emptying, bloating, excessive infusion rate, and constipation. Patients with severe or chronic GI disorders often suffer from protein or calorie malnutrition, driving the need for clinical nutrition, and supplementation.

Based on distribution channel, the industry is bifurcated into retail stores, online channels, pharmacies & drug stores, and others. Retail stores held over 40% of the U.S. clinical nutrition market share in 2022. Several consumers prefer retail stores as they offer easy access to an array of supplements designed to address different nutritional needs. Moreover, the increasing efforts by retail giants worldwide to expand their geographic footprint will spur industry growth.